CMG Pharmaceutical Co., Ltd. (058820.KQ)
KRW 1883.0
(-0.79%)
KRW 1883.0
(-0.79%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 93.9 Billion | 82.19 Billion | 69.47 Billion | 64.45 Billion | 50.74 Billion | 4.86 Billion |
| Cost of Revenue | 50.2 Billion | 41.29 Billion | 36.02 Billion | 33.24 Billion | 25.73 Billion | 3.27 Billion |
| Gross Profit | 43.7 Billion | 40.9 Billion | 33.45 Billion | 31.21 Billion | 25 Billion | 1.59 Billion |
| Operating Expenses | 37.86 Billion | 37.92 Billion | 31.79 Billion | 29.38 Billion | 22.62 Billion | 1.33 Billion |
| Selling, General and Administrative Expenses | 35.68 Billion | 17.21 Billion | 14.32 Billion | 12.1 Billion | 19.6 Billion | 468.64 Million |
| Research and Development Expenses | 2.18 Billion | 3.31 Billion | 3.26 Billion | 3.08 Billion | 1.72 Billion | - |
| Other Expenses | - | 361.45 Million | 113.53 Million | 47.32 Million | - | - |
| Cost and Expenses | 88.18 Billion | 79.21 Billion | 67.81 Billion | 62.63 Billion | 48.36 Billion | 4.6 Billion |
| Operating Income | 5.72 Billion | 2.98 Billion | 1.66 Billion | 1.82 Billion | 2.25 Billion | 352.05 Million |
| Interest Expense | 79.54 Million | 15.27 Million | 20.69 Million | 22.85 Million | 8.59 Million | - |
| Income Tax Expense | 275.68 Million | -866.95 Million | 383.62 Million | 353.84 Million | 679.84 Million | 91.88 Million |
| Earnings before Tax | 6.73 Billion | -1.25 Billion | 3.54 Billion | 568.83 Million | 3.32 Billion | 268.43 Million |
| Net Income | 6.45 Billion | -388.13 Million | 3.16 Billion | 214.99 Million | 2.64 Billion | 176.55 Million |
| Earnings Per Share Basic | 46.00 | -13.96 | 23.00 | 2.00 | 0.02 | 6.31 |
| Earnings Per Share Diluted | 46.48 | -13.96 | 23.00 | 2.00 | 0.02 | 6.31 |
| Weighted Average Shares Outstanding | 140.33 Million | 27.8 Million | 28.5 Million | 28.55 Million | 122.04 Billion | 27.97 Million |
| Weighted Average Shares Outstanding (Diluted) | 138.89 Million | 27.8 Million | 28.48 Million | 28.56 Million | 121.54 Billion | 27.96 Million |
| Gross Margin | 0.47 | 0.50 | 0.48 | 0.48 | 0.49 | 0.33 |
| EBIT Margin | 0.06 | 0.07 | 0.09 | 0.05 | 0.08 | 0.11 |
| Profit Margin | 0.07 | -0.00 | 0.05 | 0.00 | 0.05 | 0.04 |
| EBITDA | 5.59 Billion | 5.26 Billion | 6.06 Billion | 3.02 Billion | 4.7 Billion | 4.41 Billion |
| Earnings Before Tax Margin | 0.06 | 0.04 | 0.02 | 0.03 | 0.04 | 0.07 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 24.85 Billion | 22.81 Billion | 93.9 Billion | 21.98 Billion | 23.53 Billion | 25.43 Billion |
| Cost of Revenue | 14.26 Billion | 12.41 Billion | 50.2 Billion | 12.75 Billion | 12.77 Billion | 12.52 Billion |
| Gross Profit | 10.59 Billion | 10.39 Billion | 43.7 Billion | 9.22 Billion | 10.76 Billion | 12.91 Billion |
| Operating Expenses | 10.27 Billion | 686.33 Million | 40.66 Billion | 10.24 Billion | 9.93 Billion | 10.42 Billion |
| Selling, General and Administrative Expenses | 4.42 Billion | 10.28 Billion | - | 4.75 Billion | 4.71 Billion | 4.79 Billion |
| Research and Development Expenses | 331.57 Million | 89.81 Million | - | 436.43 Million | 273.19 Million | 659.72 Million |
| Other Expenses | -9.41 Million | 1.33 Million | -40.79 Million | -5.64 Million | -44.13 Million | -74.48 Million |
| Cost and Expenses | 24.53 Billion | 12.41 Billion | 90.86 Billion | 23 Billion | 22.7 Billion | 22.95 Billion |
| Operating Income | 315.71 Million | 110.1 Million | 3.03 Billion | -1.02 Billion | 836.35 Million | 2.48 Billion |
| Interest Expense | 149.09 Million | 17.62 Million | 79.54 Million | 30.28 Million | 12.29 Million | 20.92 Million |
| Income Tax Expense | 1.35 Billion | 117.79 Million | 275.68 Million | -28.33 Million | -770.94 Thousand | 304.78 Million |
| Earnings before Tax | 7.34 Billion | 2.35 Billion | 6.73 Billion | -2.67 Billion | 2.7 Billion | 4 Billion |
| Net Income | 5.98 Billion | 2.24 Billion | 6.45 Billion | -2.64 Billion | 2.7 Billion | 3.69 Billion |
| Earnings Per Share Basic | 43.00 | 16.13 | - | -95.80 | 19.00 | 27.00 |
| Earnings Per Share Diluted | 27.00 | 16.13 | - | -95.85 | 19.00 | 25.00 |
| Weighted Average Shares Outstanding | 139.12 Million | 27.61 Million | 27.71 Million | 27.63 Million | 27.8 Million | 27.8 Million |
| Weighted Average Shares Outstanding (Diluted) | 221.56 Million | 27.62 Million | 27.71 Million | 27.62 Million | 27.8 Million | 27.8 Million |
| Gross Margin | 0.43 | 0.46 | 0.47 | 0.42 | 0.46 | 0.51 |
| EBIT Margin | 0.16 | 0.46 | - | -0.05 | 0.15 | 0.20 |
| Profit Margin | 0.24 | 0.10 | 0.07 | -0.12 | 0.12 | 0.15 |
| EBITDA | 3.89 Billion | 10.39 Billion | - | -1.12 Billion | 3.44 Billion | 4.99 Billion |
| Earnings Before Tax Margin | 0.01 | 0.00 | 0.03 | -0.05 | 0.04 | 0.10 |
600785
5280
1361
LLAP
8081
002910